Target intelligence / Profile preview

Envelope Glycoprotein 120 (HIV-1) (gp120)

Target
gp120
Molecular classification
Glycoprotein, Viral Envelope Protein
01

Overview

Envelope glycoprotein 120 (gp120) is a surface-exposed glycoprotein of the human immunodeficiency virus type 1 (HIV-1). It is essential for viral entry into host cells, mediating attachment to specific cell surface receptors (CD4 and CCR5 or CXCR4) and initiating the fusion process required for infection. It is a challenging vaccine target due to its heavy glycosylation, structural flexibility, and conformational masking.

02

Mechanism of action

Target of neutralizing antibodies; involved in viral entry, thus drugs could target its interaction with CD4 or co-receptors.

03

Biological functions

Viral entry into host cellsCD4 receptor bindingCCR5/CXCR4 co-receptor engagementMembrane fusion
04

Disease associations

InfectionHIV-1 pathogenesisAIDS
05

Safety considerations

High variability and glycosylation make it difficult to target with drugs or vaccines.Conformational masking further complicates immune recognition.

Beyond the preview

Go deeper on Envelope Glycoprotein 120 (HIV-1) (gp120).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envelope Glycoprotein 120 (HIV-1) (gp120).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call